Myriad Genetics (MYGN) Divestments (2020 - 2021)
Myriad Genetics (MYGN) posted quarterly Divestments of $379.1 million for Q3 2021, up 1679.81% YoY from $21.3 million in Q3 2020, and up 1679.81% sequentially from $21.3 million in Q3 2020.
Myriad Genetics (MYGN) Divestments (2020 - 2021) Analysis & Trends
Myriad Genetics has disclosed Divestments across 2 years of filings, most recently posting $379.1 million for Q3 2021.
- In Q3 2021, Divestments rose 1679.81% year-over-year to $379.1 million; the TTM figure through Dec 2024 stood at $379.1 million (changed 0.0% YoY), while the FY2024 annual figure was $8.8 million, changed N/A from the prior year.
- Divestments advanced to $379.1 million in Q3 2021, from $21.3 million in the prior quarter.
- Over the last five years, Divestments for MYGN reached as high as $379.1 million in Q3 2021 and fell as low as -$21.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 379.10 Mn |
| Sep 30, 2020 | 21.30 Mn |
| Jun 30, 2020 | -21.30 Mn |
| Mar 31, 2020 | 21.30 Mn |